Title | A statistical model of diurnal variation in human growth hormone. |
Publication Type | Journal Article |
Year of Publication | 2003 |
Authors | Klerman EB, Adler GK, Jin M, Maliszewski AM, Brown EN |
Journal | Am J Physiol Endocrinol Metab |
Volume | 285 |
Issue | 5 |
Pagination | E1118-26 |
Date Published | 2003 Nov |
ISSN | 0193-1849 |
Keywords | Adult, Circadian Rhythm, Female, Half-Life, Human Growth Hormone, Humans, Mathematics, Metabolic Clearance Rate, Middle Aged, Models, Biological, Models, Statistical, Sleep |
Abstract | The diurnal pattern of growth hormone (GH) serum levels depends on the frequency and amplitude of GH secretory events, the kinetics of GH infusion into and clearance from the circulation, and the feedback of GH on its secretion. We present a two-dimensional linear differential equation model based on these physiological principles to describe GH diurnal patterns. The model characterizes the onset times of the secretory events, the secretory event amplitudes, as well as the infusion, clearance, and feedback half-lives of GH. We illustrate the model by using maximum likelihood methods to fit it to GH measurements collected in 12 normal, healthy women during 8 h of scheduled sleep and a 16-h circadian constant-routine protocol. We assess the importance of the model components by using parameter standard error estimates and Akaike's Information Criterion. During sleep, both the median infusion and clearance half-life estimates were 13.8 min, and the median number of secretory events was 2. During the constant routine, the median infusion half-life estimate was 12.6 min, the median clearance half-life estimate was 11.7 min, and the median number of secretory events was 5. The infusion and clearance half-life estimates and the number of secretory events are consistent with current published reports. Our model gave an excellent fit to each GH data series. Our analysis paradigm suggests an approach to decomposing GH diurnal patterns that can be used to characterize the physiological properties of this hormone under normal and pathological conditions. |
DOI | 10.1152/ajpendo.00562.2002 |
Alternate Journal | Am J Physiol Endocrinol Metab |
PubMed ID | 12888486 |
Grant List | K01-AG-00661 / AG / NIA NIH HHS / United States R01-AR-43130 / AR / NIAMS NIH HHS / United States R01-GM-53559 / GM / NIGMS NIH HHS / United States M01-RR-20635 / RR / NCRR NIH HHS / United States M01 RR002635 / RR / NCRR NIH HHS / United States K02-MH-61637 / MH / NIMH NIH HHS / United States P01 AG009975 / AG / NIA NIH HHS / United States K01 AG000661-05 / AG / NIA NIH HHS / United States |
Related Institute:
Molecular Imaging Innovations Institute (MI3)